3513659334

231

induces its association with membranę type 1 matrix metalloproteinase. J Biol Chem. 279:52132-52140.

Laderoutc, K.R., R.M. Alarcon, M.D. Brody, J.M. Calaoagan, E.Y. Chen, A.M. Knapp, Z. Yun, N.C. Denko, and A.J. Giaccia. 2000. Opposing cffects of hypoxia on expression of the angiogenic inhibitor thrombospondin 1 and the angiogenic inducer vascular endothelial growth factor. Clin Cancer Res. 6:2941-2950.

Laurenzana, A., M. Balliu, C. Cellai, M.N. Rómanelli, and F. Paoletti. 2013. Effectiveness of the histone deacetylase inhibitor (S)-2 against LNCaP and PC3 human prostatę cancer cells. PLoS One. 8:e58267.

Lawler, S., X.H. Feng, R.H. Chen, E.M. Maruoka, C.W. Turek, I. Griswold-Prenner, and R. Derynck. 1997. The type II transforming growth factor-beta receptor autophosphorylates not only on serine and threonine but also on tyrosine residues. J Biol Chem. 272:14850-14859.

Lee, M.K., C. Pardoux, M.C. Hall, P.S. Lee, D. Warburton, J. Qing, S.M. Smith, and R. Derynck. 2007. TGF-beta activates Erk MAP kinasc signalling through direct phosphorylation of ShcA. EMBO J. 26:3957-3967.

Lee, Y.S., K.H. Lim, X. Guo, Y. Kawaguchi, Y. Gao, T. Barrientos, P. Ordentlich, X.F. Wang, C.M. Counter, and T.P. Yao. 2008. The cytoplasmic deacetylase HDAC6 is required forefficient oncogenic tumorigenesis. Cancer Res. 68:7561-7569.

Lehmann, A., C. Denkert, J. Budczies, A.C. Buckendahl, S. Darb-Esfahani, A. Noske, B.M. Muller, M. Bahra, P. Neuhaus, M. Dietel, G. Kristiansen, and W. Weichert. 2009. High class I HDAC activity and expression are associatcd with RelA/p65 activation in panereatie cancer in vitro and in vivo. BMC cancer. 9:395.

Lehmann, K., E. Janda, C.E. Picrreux, M. Rytomaa, A. Schulze. M. McMahon, C.S. Hill, H. Beug, and J. Downward. 2000. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to inereased malignancy in epithelial cells. Genes Dew 14:2610-2622.

Levin, V.A., S. Panchabhai, L. Shen, and K..A. Baggerly. 2012. Protein and phosphoprotein levels in glioma and adenocarcinoma celi lines grown in normoxia and hypoxia in monolayer and three-dimensional cultures. Proteome science. 10:5.

Levy, L., and C.S. Hill. 2006. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev. 17:41-58.

Li, M.O., Y.Y. Wan, S. Sanjabi, A.K. Robertson, and R.A. Flavell. 2006. Transforming growth factor-beta regulation of immune responses. Annual review of immunology. 24:99-146.

Li, X.Y., I. Ota, I. Yana, F. Sabeh, and S.J. Weiss. 2008a. Molecular dissection of the structural machinery underlying the tissue-invasive activity of membranę typc-1 matrix metalloproteinase. Mol Biol Celi. 19:3221-3233.

Li, Y., X. Zhang, R.D. Polakiewicz, T.P. Yao, and M.J. Comb. 2008b. HDAC6 is required for epidermal growth factor-induced beta-catenin nuclear localization. J Biol Chem. 283:12686-12690.

Liao, D., C. Corle, T.N. Seagroves, and R.S. Johnson. 2007. Hypoxia-inducible factor-lalpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. Cancer Res. 67:563-572.

Lin, H.Y., C.S. Chen, S.P. Lin, and J.R. Weng. 2006. Targeting histone deacetylase in cancer therapy. Med Res Rew 26:397-413.